167 related articles for article (PubMed ID: 21728008)
1. [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].
Saar M; Kamradt J; Jung V; Stöckle M; Unteregger G
Urologe A; 2011 Aug; 50(8):961-7. PubMed ID: 21728008
[TBL] [Abstract][Full Text] [Related]
2. [Development of a three-dimensional primary prostate cancer cell culture model].
Jung V; Saar M; Grobholz R; Stöckle M; Unteregger G; Kamradt J
Urologe A; 2008 Sep; 47(9):1199-204. PubMed ID: 18682911
[TBL] [Abstract][Full Text] [Related]
3. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy.
Cheng L; Sun J; Pretlow TG; Culp J; Yang NS
J Natl Cancer Inst; 1996 May; 88(9):607-11. PubMed ID: 8609662
[TBL] [Abstract][Full Text] [Related]
4. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
5. Development of seven new human prostate tumor xenograft models and their histopathological characterization.
van Weerden WM; de Ridder CM; Verdaasdonk CL; Romijn JC; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Am J Pathol; 1996 Sep; 149(3):1055-62. PubMed ID: 8780407
[TBL] [Abstract][Full Text] [Related]
6. Breaking through a roadblock in prostate cancer research: an update on human model systems.
Toivanen R; Taylor RA; Pook DW; Ellem SJ; Risbridger GP
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):122-31. PubMed ID: 22342674
[TBL] [Abstract][Full Text] [Related]
7. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
[TBL] [Abstract][Full Text] [Related]
9. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
[TBL] [Abstract][Full Text] [Related]
10. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
[TBL] [Abstract][Full Text] [Related]
11. Animal models of prostate cancer.
Russell PJ; Voeks DJ
Methods Mol Med; 2003; 81():89-112. PubMed ID: 12725117
[No Abstract] [Full Text] [Related]
12. The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.
Krupski T; Harding MA; Herce ME; Gulding KM; Stoler MH; Theodorescu D
Growth Factors; 2001; 18(4):287-302. PubMed ID: 11519827
[TBL] [Abstract][Full Text] [Related]
13. Current experimental human tissue-derived models for prostate cancer research.
Kato M; Sasaki T; Inoue T
Int J Urol; 2021 Feb; 28(2):150-162. PubMed ID: 33247498
[TBL] [Abstract][Full Text] [Related]
14. [Biological behavior of prostate cancer cells in 3D culture systems].
Watanabe M; Takagi A
Yakugaku Zasshi; 2008 Jan; 128(1):37-44. PubMed ID: 18176054
[TBL] [Abstract][Full Text] [Related]
15. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
Denmeade SR; Sokoll LJ; Chan DW; Khan SR; Isaacs JT
Prostate; 2001 Jun; 48(1):1-6. PubMed ID: 11391681
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
[TBL] [Abstract][Full Text] [Related]
17. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
[TBL] [Abstract][Full Text] [Related]
18. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
[TBL] [Abstract][Full Text] [Related]
19. Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies.
Voeks DJ; Martiniello-Wilks R; Russell PJ
Urol Oncol; 2002; 7(3):111-8. PubMed ID: 12474544
[TBL] [Abstract][Full Text] [Related]
20. Establishment of two human prostate cancer cell lines derived from a single bone metastasis.
Navone NM; Olive M; Ozen M; Davis R; Troncoso P; Tu SM; Johnston D; Pollack A; Pathak S; von Eschenbach AC; Logothetis CJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2493-500. PubMed ID: 9815652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]